Effectiveness and Adherence of Dry Eye Patients Who Switched from Short- to Long-Acting Diquafosol Ophthalmic Solution

Long-acting (lasting extend) diquafosol ophthalmic solution 3% (DQSLX) is administered three times daily versus six times daily for the currently approved diquafosol ophthalmic solution (DQS). We investigated the efficacy and adherence of switching from DQS to DQSLX in patients with dry eye disease....

Descripción completa

Detalles Bibliográficos
Autores principales: Ishikawa, Sho, Sasaki, Takanori, Maruyama, Takahumi, Murayama, Koichiro, Shinoda, Kei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342394/
https://www.ncbi.nlm.nih.gov/pubmed/37445527
http://dx.doi.org/10.3390/jcm12134495

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342394/
https://www.ncbi.nlm.nih.gov/pubmed/37445527
http://dx.doi.org/10.3390/jcm12134495

Ejemplares similares